Boosting translational cancer research

Developing new anti-cancer treatments is expensive, and national, public funding organisations across Europe dedicate substantial resources to this task. Linking their research programmes helps to ensure these funds are used to best effect. The ERA-Net Transcan is now continuing as the ERA-Net Cofund Transcan-2 network, fostering long-term transnational research synergy.

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia


 

Published: 8 June 2016  
Related theme(s) and subtheme(s)
Health & life sciences
Research policyHorizon 2020
Special CollectionsCancer
Countries involved in the project described in the article
Austria  |  Belgium  |  Estonia  |  France  |  Germany  |  Greece  |  Hungary  |  Israel  |  Italy  |  Latvia  |  Netherlands  |  Norway  |  Poland  |  Portugal  |  Slovakia  |  Slovenia  |  Spain  |  Turkey
Add to PDF "basket"

Boosting translational cancer research

Picture of picture of syringe and words cancer treatment written on the paper

© cacaroot - fotolia.com

Updated on 29 March 2018

Transcan was set up in 2011 by public funding organisations supporting translational cancer research – research that aims to develop promising scientific leads into new ways of predicting, detecting and treating cancer. It spanned 16 EU countries as well as Israel, Norway and Turkey. The partners, including several well-known cancer charities, funded 30 projects with a total of €33 million from national research budgets. Projects focused on various aspects of cancer prevention as well as biomarkers that enable personalised medicine.

Transcan-2 continues to foster coherence and synergies among the participants’ national and charity funding programmes. Based on an analysis of research needs and opportunities, it has issued four calls for proposals,and so far funded 37 projects, worth € 35 million, to advance work in selected priority areas. Since 2011, these calls have been supported by the EU with a total of €8.6 million.

A first call, which closed in 2015, focused on the differences among tumours in terms of response to therapy and potential recurrence. The second and third calls were dedicated to immune system-based cancer therapy and non- or minimally-invasive methods for the early detection and/or progression of cancer. A fourth call, on rare cancers, is under evaluation.

Further work in Transcan-2 will be aimed at developing strategies to extend the network, enhance its coordination and ensure efficient dissemination of outcomes conducted both by the consortium and funded projects. In addition, partners will be monitoring projects' contents and performing a critical assessment of their combined programme.

Project details

  • Project acronym: TRANSCAN-2
  • Participants: Italy (Coordinator), Spain, Austria, Latvia, France, Germany, Greece, Israel, Netherlands, Norway, Portugal, Slovakia, Turkey, Poland, Belgium, Hungary, Estonia, Slovenia
  • Project N°: 643638
  • Total costs: € 22 568 750
  • EU contribution: € 6 672 187
  • Duration: January 2015 to December 2019

See also

 

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project website
Project details